FDA inspection
Taro Pharmaceuticals U.S.A., Inc.: FDA inspection ending May 29, 2009
FDA inspection 592198 · Voluntary Action Indicated (VAI) · Hawthorne, NY
Key facts
| Inspection ID | 592198 |
|---|---|
| Firm | Taro Pharmaceuticals U.S.A., Inc. |
| FEI number | 2435212 |
| Address | 3 Skyline Dr |
| City | Hawthorne |
| State | NY |
| ZIP | 10532 |
| Country | United States |
| Fiscal year | 2009 |
| Inspection end date | May 29, 2009 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data